Free Trial
TSE:EXE

Extendicare (EXE) Stock Price, News & Analysis

Extendicare logo
C$13.01 -0.09 (-0.69%)
As of 04:00 PM Eastern

About Extendicare Stock (TSE:EXE)

Key Stats

Today's Range
C$12.98
C$13.13
50-Day Range
C$12.27
C$14.14
52-Week Range
C$8.61
C$15.24
Volume
77,960 shs
Average Volume
183,986 shs
Market Capitalization
C$1.09 billion
P/E Ratio
16.59
Dividend Yield
3.69%
Price Target
C$14.15
Consensus Rating
Moderate Buy

Company Overview

Extendicare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
14th Percentile Overall Score

EXE MarketRank™: 

Extendicare scored higher than 14% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Extendicare has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Extendicare has only been the subject of 2 research reports in the past 90 days.

  • Read more about Extendicare's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Extendicare is 16.59, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.67.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Extendicare is 16.59, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 31.26.

  • Price to Book Value per Share Ratio

    Extendicare has a P/B Ratio of 9.32. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for EXE.
  • Dividend Leadership

    Extendicare is a leading dividend payer. It pays a dividend yield of 4.42%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Extendicare does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Extendicare is 61.20%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Extendicare's dividend.
  • Short Interest

    There is no current short interest data available for EXE.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Extendicare this week, compared to 1 article on an average week.
  • Search Interest

    Only 8 people have searched for EXE on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Extendicare insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    13.92% of the stock of Extendicare is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 19.16% of the stock of Extendicare is held by institutions.

  • Read more about Extendicare's insider trading history.
Receive EXE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EXE Stock News Headlines

Why More Investors Are Using Family Trusts to Protect Their Wealth
For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026. If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest.tc pixel
Public market insider buying at Extendicare (EXE)
See More Headlines

EXE Stock Analysis - Frequently Asked Questions

Extendicare's stock was trading at C$10.63 at the beginning of the year. Since then, EXE shares have increased by 22.4% and is now trading at C$13.01.

Extendicare Inc. (TSE:EXE) posted its quarterly earnings data on Tuesday, November, 12th. The company reported $0.19 EPS for the quarter. Extendicare had a trailing twelve-month return on equity of 64.13% and a net margin of 4.48%.
Read the conference call transcript
.

Shares of EXE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Extendicare investors own include Enbridge (ENB), Enterprise Products Partners (EPD), Algonquin Power & Utilities (AQN), Bank of Nova Scotia (BNS), NVIDIA (NVDA), Pembina Pipeline (PPL) and BCE (BCE).

Company Calendar

Last Earnings
11/12/2024
Record date for 8/15 Dividend
7/31/2025
Ex-Dividend for 8/15 Dividend
7/31/2025
Dividend Payable
8/15/2025
Today
8/28/2025
Ex-Dividend for 9/15 Dividend
8/29/2025
Record date for 9/15 Dividend
9/15/2025
Dividend Payable
9/15/2025

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Medical Care Facilities
Sub-Industry
N/A
Current Symbol
TSE:EXE
CIK
N/A
Fax
N/A
Employees
23,000
Year Founded
N/A

Price Target and Rating

High Price Target
C$16.10
Low Price Target
C$11.00
Potential Upside/Downside
+8.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
C$0.78
Trailing P/E Ratio
16.59
Forward P/E Ratio
21.21
P/E Growth
N/A
Net Income
C$65.46 million
Net Margins
4.48%
Pretax Margin
N/A
Return on Equity
64.13%
Return on Assets
7.16%

Debt

Debt-to-Equity Ratio
283.02
Current Ratio
0.62
Quick Ratio
0.98

Sales & Book Value

Annual Sales
C$1.46 billion
Price / Sales
0.74
Cash Flow
C$4.06 per share
Price / Cash Flow
3.20
Book Value
C$1.40 per share
Price / Book
9.32

Miscellaneous

Outstanding Shares
83,467,000
Free Float
N/A
Market Cap
C$1.09 billion
Optionable
Not Optionable
Beta
1.26
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (TSE:EXE) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners